# K020071: Viridis Derma Laser

- Pathway: 510(k) (Traditional)
- Applicant: Quantel Medical
- Decided: Apr 5, 2002 after 86 days
- Product code: GEX (Powered Laser Surgical Instrument)
- Device class: 2
- Regulation: 21 CFR 878.4810
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K933880 (1994). 11 ancestors in all.
92 later devices descend from it; 3 cite it directly.
0 of 104 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K983020: Compact KTP Laser, Cosmos Medical Technology (1998) Summary page 1.
- K964074: Diolite 532, Iriderm Div. (1997) Summary page 1.
- K981447: Dio-Light 60 Laser System, Nidek, Inc. (1998) Summary page 1.
- K003202: Family of Altus Medical Coolglide Aesthetic Lasers, Models I & II, Altus Medical (2001) Summary page 1.
- K001784: Viridis Laser, Cosmos Medical Technology (2000) Summary page 1.
- K970667: Nuvo-Lase 660 Laser System, American Laser Medical (1997) Summary page 1.

## Most influential descendants
- K091534: Lightlas Model 532 (2009), 72 descendants of its own
- K100558: Quanta Diode Laser System (2010), 68 descendants of its own
- K102755: Ceralas E/ 1470NM Fiber-Coupled Diode Laser Family; Crealas HPD Multiwavelenght 980NM/ 1470NM Fiber-Coupled Diode Laser (2010), 46 descendants of its own
- K110080: Radial-Emitting Shaped Fiber Optic Delivery System (2011), 26 descendants of its own
- K120810: Fiberoptic Laser Delivery System (2012), 24 descendants of its own

## Indications for use
The Viridis Derma laser is intended for photocoagulation of pigmented lesions in dermatology. These include the following specific applications: Benign Vascular Lesions Facial Telangiectasias Port Wine Stains Café au-lait Erythrosis Benign Pigmented Lesions Cuperosis Senile Lentigo Keratoses Hemangiomas (spider and cherry/ strawberry) Dermatosis Papulosis Nigra (DPN) strawberry) Leg Telangiectasia - only as a complement to sclerotherapy and for small superficial red vessels

Source page: https://510kreport.com/device/K020071
Methodology: https://510kreport.com/methodology